Seeking Alpha

NBS
NeoStem, Inc

5/26/2012, 5:05 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
NBS Market Currents more »
Currently, there are no Market Currents on NBS.
NBS in Focus more »
NBS News more »
NBS Latest Transcript more »
Currently, there are no transcripts for NBS.
NBS Cramer more »
Currently, there are no Cramer articles on NBS.
NBS Instablog posts more »
Write a post on NBS
NBS StockTalks
NBS vs. ETF Alternatives
Company Description

NeoStem, Inc. (“NeoStem”) is engaged in the
development and manufacturing of cell-based therapies in the U.S. and globally.
Its January, 2011 acquisition of Progenitor Cell Therapy ("PCT"), and
its July 14, 2011 announcement of the signing of a merger agreement to acquire
Amorcyte, Inc.... More